logo

For the Inventor, By the Inventor

Catskill, NY, United States of America

Henry R DuBois, Iii

This inventor holds 2 USPTO granted patents. Top assignee: Neurocrine Biosciences, Inc.. Active years: 2005-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henry R DuBois, Iii. Retrieved from https://idiyas.com/inventor/henry-r-dubois-iii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal2 out of 123 
 
Neurocrine Biosciences, Inc.
 patents

Years Active: 2005-2008

Loading Chart...
2 patents (USPTO):Explore Patents
1. 7459458 - Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto (2008-12-02),
2. 6903106 - Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto (2005-06-07),

Title: The Innovative Genius of Henry R. DuBois, III

Introduction

Henry R. DuBois, III is a notable inventor based in Catskill, NY, who has made significant contributions in the field of pharmaceutical innovations. With a total of two patents to his name, he has focused primarily on developing advanced compositions and methods aimed at treating conditions such as insomnia.

Latest Patents

DuBois's latest patents include the development of a polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide. This innovation, specifically labeled as Polymorph Form III, is designed for use as a sedative-hypnotic, anxiolytic, anticonvulsant, and/or skeletal muscle relaxant agent. The related compositions and methods disclosed in his patents highlight their application in effectively treating insomnia, showcasing his commitment to addressing pressing health concerns through innovation.

Career Highlights

Henry R. DuBois, III currently works at Neurocrine Biosciences, Inc., a company recognized for its dedication to developing novel therapies for neurological and endocrine-related disorders. His work at Neurocrine has facilitated the exploration and advancement of cutting-edge treatments, contributing to the broader mission of improving patient health and quality of life.

Collaborations

Throughout his career, DuBois has collaborated with esteemed colleagues such as Scott E. Zook and Donald Nicholas Hettinger. These partnerships have played a vital role in fostering creativity and innovation, bringing together diverse expertise to tackle complex challenges in pharmaceutical development.

Conclusion

In conclusion, Henry R. DuBois, III exemplifies the spirit of innovation within the pharmaceutical industry. His two patents demonstrate his commitment to improving therapeutic options for patients, especially those suffering from insomnia. With a solid foundation in research and collaboration at Neurocrine Biosciences, he continues to pave the way for future advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…